Momo Hirata - Dept Pulmonol, Yokohama City Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety of Benralizumab in Elderly Patients with Severe Eosinophilic Asthma

Kohei Somekawa,Keisuke Watanabe,Kenichi Seki,Suguru Muraoka,Ami Izawa,Ayami Kaneko,Yukiko Otsu,Momo Hirata,Sousuke Kubo,Katsushi Tanaka,Ryo Nagasawa,Hiromi Matsumoto,Kota Murohashi, Hiroaki Fuji,Ayako Aoki,Nobuyuki Horita,Yu Hara,Nobuaki Kobayashi,Makoto Kudo,Takeshi Kaneko

EUROPEAN CLINICAL RESPIRATORY JOURNALno. 1 (2024)

引用0浏览0WOS引用

Geographic and Economic Influences on Benralizumab Prescribing for Severe Asthma in Japan

Nobuaki Kobayashi,Hiromi Matsumoto,Kohei Somekawa,Ayami Kaneko,Nobuhiko Fukuda,Suguru Muraoka, Yukiko Ohtsu,Momo Hirata,Ryo Nagasawa,Sousuke Kubo,Kota Murohashi,Hiroaki Fujii,Ayako Aoki,Keisuke Watanabe,Nobuyuki Horita,Yu Hara,Takeshi Kaneko

SCIENTIFIC REPORTS（2024）

引用0浏览0WOSNATURE引用

ILD-GAP Combined with the Monocyte Ratio Could Be a Better Prognostic Prediction Model Than ILD-GAP in Patients with Interstitial Lung Diseases

Momo Hirata,Yu Hara,Hiroaki Fujii,Kota Murohashi,Yusuke Saigusa, Shiqi Zhao,Miyu Kobayashi,Ryo Nagasawa,Yoichi Tagami,Ami Izawa,Yukiko Otsu,Keisuke Watanabe,Nobuyuki Horita,Nobuaki Kobayashi,Takeshi Kaneko

BMC PULMONARY MEDICINEno. 1 (2024)

引用0浏览0WOS引用

HLA-DQA1*01:03 and DQB1*06:01 Are Risk Factors for Severe COVID-19 Pneumonia

Katsushi Tanaka, Akira Meguro,Yu Hara, Lisa Endo,Ami Izawa, Suguru Muraoka,Ayami Kaneko,Kohei Somekawa,Momo Hirata,Yukiko Otsu,Hiromi Matsumoto,Ryo Nagasawa, Sosuke Kubo,Kota Murohashi,Ayako Aoki,Hiroaki Fujii, Keisuke Watanabe,Nobuyuki Horita, Hideaki Kato,Nobuaki Kobayashi,Ichiro Takeuchi,Atsushi Nakajima,Hidetoshi Inoko, Nobuhisa Mizuki,Takeshi Kaneko

HLAno. 1 (2024)

引用0浏览0引用

High Red Blood Cell Distribution Width Attenuates the Effectiveness of Immune Checkpoint Inhibitor Therapy: an Exploratory Study Using a Clinical Data Warehouse

Hiromi Matsumoto, Taichi Fukushima,Nobuaki Kobayashi, Yuuki Higashino,Suguru Muraoka, Yukiko Ohtsu,Momo Hirata,Kohei Somekawa,Ayami Kaneko,Ryo Nagasawa,Sousuke Kubo,Katsushi Tanaka,Kota Murohashi,Hiroaki Fujii,Keisuke Watanabe,Nobuyuki Horita,Yu Hara,Takeshi Kaneko

PLOS ONEno. 8 (2024)

引用0浏览0WOS引用

Serum Heme Oxygenase-1 As a Prognostic Biomarker in Patients with Acute Exacerbation of Interstitial Lung Disease

Yoichi Tagami,Yu Hara,Kota Murohashi,Ryo Nagasawa,Hiroaki Fujii,Ami Izawa,Aya Yabe,Yusuke Saigusa,Miyu Kobayashi,Masafumi Shiida,Momo Hirata,Yukiko Otsu,Keisuke Watanabe,Nobuyuki Horita,Nobuaki Kobayashi,Takeshi Kaneko

SCIENTIFIC REPORTSno. 1 (2023)

引用0浏览0WOS引用

T‐cell Response to Phytohemagglutinin in the Interferon‐γ Release Assay As a Potential Biomarker for the Response to Immune Checkpoint Inhibitors in Patients with Non‐small Cell Lung Cancer

Chisato Kamimaki,Nobuaki Kobayashi,Momo Hirata,Kohei Somekawa,Nobuhiko Fukuda,Sousuke Kubo,Seigo Katakura,Shuhei Teranishi,Keisuke Watanabe,Nobuyuki Horita,Yu Hara,Masaki Yamamoto,Makoto Kudo,Hongmei Piao,Takeshi Kaneko

Thoracic cancer（2021）

引用8浏览0WOS引用

A Retrospective Analysis of Risk Factors for Durvalumab Related Interstitial Lung Disease after Chemoradiotherapy in Stage III NSCLC

Nobuyuki Hirama,Masaki Yamamoto,Hiromi Kanaoka, Tatuya Muraoka,Kouhei Somekawa,Momo Hirata, Tisato Kamimaki, Syuuhei Ikeda,Sousuke Kubo, Usio Ryouta,Saki Manabe, Makoto Kudou, Takesi Kaneko

Lung cancer（2020）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn